Related by context. Frequent words. (Click for all words.) 77 Presents Positive 77 FDA Clears 76 Drug Candidate 75 Develop Novel 75 FDA Accepts 75 Completes Enrollment 73 Generic Version 72 Announces Initiation 72 Achieves Milestone 71 Initiate Phase 71 Inc Therapeutic Competitors 71 Receives FDA Clearance 70 Patient Enrollment 70 Files Shelf Registration Statement 70 Patent Covering 70 Phase III Clinical Trial 70 Signs Licensing Agreement 70 Receives Positive 70 Significantly Reduces 70 Cholesterol Drug 70 Completes Tender Offer 70 Exercises Option 70 Receives Patent 70 Initiates Phase 70 Clinical Trial Results 69 Q1 Loss Narrows 69 Blood Thinner 69 Shows Promise 69 Reports Positive 69 Announces Successful Completion 69 Discontinues 69 Reduces Risk 69 FDA Approves 69 Acquires Exclusive 69 Significantly Increases 69 Phase III Trial 69 Small Molecule 69 Seeks Approval 69 Announces Issuance 68 Study Demonstrates 68 Pivotal Phase III 68 Q3 Loss Widens 68 Recombinant Human 68 RNAi Therapeutics 68 Announces Publication 68 Receives Regulatory 68 Q4 Loss Widens 68 Announces Stockholder Approval 68 submitted Biologics License 68 FDA Warns 68 Positive Opinion 67 Patent Issued 67 Announces Termination 67 Finalizes Acquisition 67 Anti Inflammatory 67 Exclusive License 67 Q3 Loss Narrows 67 Issues Guidance 67 Announce Collaboration 67 Reconfirms 67 Q4 Loss Narrows 67 Transcept Pharmaceuticals 67 Announces Presentation 67 Q1 Loss Widens 67 Announces Signing 66 Completes Initial 66 R sorafenib tablets 66 Q2 Loss Widens 66 Q2 Loss Narrows 66 Updates Status 66 Signs Agreements 66 Preclinical Data 66 Kuvan R 66 Announces Definitive Agreement 66 Files Patent 66 Copegus R 66 Announces Commencement 66 Smallpox Vaccine 66 Patent Lawsuit 66 Announces Positive 66 Exploit collaboration 66 Chronic Hepatitis C 65 Explore Strategic Alternatives 65 Inhibits 65 Announces Shareholder Approval 65 Licensing Deal 65 Announce Exclusive 65 CHEAP ONLINE PHARMACY LOW 65 Gets Approval 65 Provides Guidance 65 NV Organon 65 Vertex Pharmaceuticals Announces 65 Develop Next Generation 65 Commercialize 65 Enters Agreement 65 Patent Infringement Case 65 Spins Off 65 Announce Completion 65 Pivotal Phase 65 Subsidiary Receives 65 Regains Compliance With